Clinical Trial: NRG HN005

NRG HN005

Status: Closed

A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer

HN005 is closed to accrual effective October 4. 2024.